当前位置:首页 - 行情中心 - 方盛制药(603998) - 财务分析 - 现金流量表

方盛制药

(603998)

  

流通市值:46.19亿  总市值:46.19亿
流通股本:4.39亿   总股本:4.39亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金470,620,751.891,769,205,435.131,235,533,947.85796,406,749.01
  收到的税费返还-817,140.02824,405.67824,405.67
  收到其他与经营活动有关的现金14,475,375.8578,412,698.0666,449,232.1939,986,016.29
  经营活动现金流入小计485,096,127.741,848,435,273.211,302,807,585.71837,217,170.97
  购买商品、接受劳务支付的现金68,306,411.52345,996,554.54252,968,227.86164,043,152.56
  支付给职工以及为职工支付的现金90,238,992.43279,890,063.37206,545,038.99143,436,506.5
  支付的各项税费80,968,479.2213,791,997.41143,270,208.395,002,019.42
  支付其他与经营活动有关的现金165,396,191.6624,124,762.43475,147,864.82305,247,124.82
  经营活动现金流出小计404,910,074.751,463,803,377.751,077,931,339.97707,728,803.3
  经营活动产生的现金流量净额80,186,052.99384,631,895.46224,876,245.74129,488,367.67
二、投资活动产生的现金流量:
  收回投资收到的现金129,080,000794,744,724.59559,645,427.6247,001,788.89
  取得投资收益收到的现金138,096.35688,175.22443,534.59257,825.18
  处置固定资产、无形资产和其他长期资产收回的现金净额603,490.12,613,8711,923,0201,309,140
  处置子公司及其他营业单位收到的现金净额-24,398,706.2624,398,706.2624,398,706.26
  收到的其他与投资活动有关的现金3,000,00076,789,05153,729,00047,729,000
  投资活动现金流入小计132,821,586.45899,234,528.07640,139,688.45320,696,460.33
  购建固定资产、无形资产和其他长期资产支付的现金22,141,722.18102,516,244.1163,509,679.0147,298,903.28
  投资支付的现金164,080,000715,000,000525,000,000260,000,000
  投资活动现金流出小计186,221,722.18817,516,244.11588,509,679.01307,298,903.28
  投资活动产生的现金流量净额-53,400,135.7381,718,283.9651,630,009.4413,397,557.05
三、筹资活动产生的现金流量:
  吸收投资收到的现金11,065,37522,620,3369,080,0004,625,000
  其中:子公司吸收少数股东投资收到的现金11,065,37522,620,3369,080,0004,625,000
  取得借款收到的现金170,000,000363,400,000333,400,000329,400,000
  筹资活动现金流入小计181,065,375386,020,336342,480,000334,025,000
  偿还债务支付的现金195,000,000638,550,000508,750,000486,750,000
  分配股利、利润或偿付利息支付的现金68,358,906.36200,276,402.18197,375,585.2128,446,788.17
  其中:子公司支付给少数股东的股利、利润-7,006,5007,006,5007,006,500
  支付其他与筹资活动有关的现金1,607,723.8241,304,984.3939,483,005.4743,063,982.19
  筹资活动现金流出小计264,966,630.18880,131,386.57745,608,590.67658,260,770.36
  筹资活动产生的现金流量净额-83,901,255.18-494,111,050.57-403,128,590.67-324,235,770.36
四、汇率变动对现金及现金等价物的影响-23,830.36-90,882.9-16,775.9-0.19
五、现金及现金等价物净增加额-57,139,168.28-27,851,754.05-126,639,111.39-181,349,845.83
  加:期初现金及现金等价物余额271,359,319.52296,022,032.75296,028,848.51296,022,032.75
  期末现金及现金等价物余额214,220,151.24268,170,278.7169,389,737.12114,672,186.92
补充资料:
  净利润-302,635,591.07-166,494,080.22
  资产减值准备-9,768,205.7-54,625.6
  固定资产和投资性房地产折旧-60,018,412.6-29,316,359.35
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-60,018,412.6-29,316,359.35
  无形资产摊销-16,616,901.38-9,533,315.01
  长期待摊费用摊销-7,815,810.21-4,055,262
  处置固定资产、无形资产和其他长期资产的损失--51,391,981.31--20,669,772.23
  固定资产报废损失-643,812.09-27,753.74
  财务费用-11,615,380.81-6,335,566.43
  投资损失--1,688,667.73--1,376,986.92
  递延所得税--2,590,015.73--667,698.79
  其中:递延所得税资产减少--1,119,216.66-339,791.29
    递延所得税负债增加--1,470,799.07--1,007,490.08
  存货的减少-32,289,097.86--7,286,195.93
  经营性应收项目的减少--62,708,250.21--31,365,812.96
  经营性应付项目的增加-57,791,029.41--30,594,313.33
  其他-175,229.28-175,229.28
  现金的期末余额-268,170,278.7-114,672,186.92
  减:现金的期初余额-296,022,032.75-296,022,032.75
  现金及现金等价物的净增加额--27,851,754.05--181,349,845.83
公告日期2026-04-252026-04-252025-10-242025-08-29
审计意见(境内)标准无保留意见
TOP↑